National Penn Investors Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$710K Sell
4,732
-326
-6% -$48.4K 0.08% 124
2015
Q4
$821K Sell
5,058
-200
-4% -$31.4K 0.09% 125
2015
Q3
$728K Sell
5,258
-70
-1% -$11K 0.08% 125
2015
Q2
$818K Sell
5,328
-363
-6% -$58.1K 0.09% 130
2015
Q1
$910K Sell
5,691
-22,959
-80% -$3.62M 0.1% 123
2014
Q4
$4.56M Sell
28,650
-662
-2% -$103K 0.52% 40
2014
Q3
$4.12M Sell
29,312
-98,011
-77% -$12.8M 0.49% 46
2014
Q2
$15.1M Sell
127,323
-38,598
-23% -$4.47M 1.77% 26
2014
Q1
$20.5M Sell
165,921
-6,348
-4% -$770K 2.42% 11
2013
Q4
$19.7M Sell
172,269
-1,937
-1% -$220K 2.2% 12
2013
Q3
$19.5M Sell
174,206
-1,661
-0.9% -$180K 2.39% 10
2013
Q2
$17.4M Buy
+175,867
New +$18.3M 2.22% 13

Other funds holding AMGN

National Penn Investors Trust's AMGN Position: Q1 2016 in Review

National Penn Investors Trust reduced its Amgen (AMGN) stake by 6.4% in Q1 2016, selling an estimated $48.4K and leaving 4,732 shares worth $710K. The position accounts for 0.08% of the portfolio, ranked #124.

National Penn Investors Trust first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $20.5M in Q1 2014. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • National Penn Investors Trust held 4,732 shares of Amgen worth $710K as of Q1 2016.
  • National Penn Investors Trust sold 326 Amgen shares in Q1 2016, an estimated $48.4K.
  • Amgen made up 0.08% of National Penn Investors Trust's portfolio in Q1 2016, its #124 holding.
  • National Penn Investors Trust first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • National Penn Investors Trust's Amgen position peaked at $20.5M in Q1 2014.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.